{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:58:11Z","timestamp":1761919091785},"reference-count":81,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.dld.2008.02.003","type":"journal-article","created":{"date-parts":[[2008,4,21]],"date-time":"2008-04-21T20:44:23Z","timestamp":1208810663000},"page":"585-598","source":"Crossref","is-referenced-by-count":20,"title":["Consensus recommendations for managing asymptomatic persistent non-virus non-alcohol related elevation of aminotransferase levels"],"prefix":"10.1016","volume":"40","author":[{"given":"F.","family":"Morisco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Pagliaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Caporaso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Sagliocca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Fargion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Smedile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Salvagnini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2008.02.003_bib1","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.20689","article-title":"Prevalence and etiology of altered liver tests: a population-based Survey in a mediterranean town","volume":"41","author":"Pendino","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2008.02.003_bib2","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/hep.1840200611","article-title":"Prevalence of chronic liver disease in the general population of northern Italy: The Dionysos study","volume":"20","author":"Bellentani","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2008.02.003_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1053\/gast.2003.50004","article-title":"Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States","volume":"124","author":"Ruhl","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.02.003_bib4","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1572-0241.2003.07486.x","article-title":"The prevalence and etiology of elevated aminotransferase levels in the United States","volume":"98","author":"Clark","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.02.003_bib5","unstructured":"Guidelines for the planning and management of NIH Consensus Development Conferences Online Bethesda (MD): National Institutes of Health, Office of the Director, Office of Medical Applications of Research; 1993 May. Updated October 2001."},{"key":"10.1016\/j.dld.2008.02.003_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-137-1-200207020-00006","article-title":"Updated definitions of healthy ranges for serum alanine aminotransferase levels","volume":"137","author":"Prati","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2008.02.003_bib7","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/jhep.2003.50229","article-title":"Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values","volume":"37","author":"Mofrad","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2008.02.003_bib8","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/bmj.38050.593634.63","article-title":"Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study","volume":"328","author":"Kim","year":"2004","journal-title":"Br Med J"},{"key":"10.1016\/j.dld.2008.02.003_bib9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jhep.2006.01.004","article-title":"Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C","volume":"44","author":"Prati","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2008.02.003_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7326\/0003-4819-137-1-200207020-00012","article-title":"Alanine Aminotransferase levels: what's normal?","volume":"137","author":"Kaplan","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2008.02.003_bib11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/hep.20818","article-title":"Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women","volume":"42","author":"Kunde","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2008.02.003_bib12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1590-8658(03)00185-3","article-title":"The Committee on HCV carriers with normal aminotransferase levels of the Italian Association for the Study of the Liver. Clinical management of HCV carriers with normal aminotransferase levels","volume":"35","author":"Puoti","year":"2003","journal-title":"Dig Liv Dis"},{"key":"10.1016\/j.dld.2008.02.003_bib13","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1111\/j.1572-0241.1999.01451.x","article-title":"Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients","volume":"94","author":"Daniel","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.02.003_bib14","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/bmj.322.7281.276","article-title":"How are abnormal results for liver function tests dealt with in primary care? Audit of yield and impact?","volume":"322","author":"Sherwood","year":"2001","journal-title":"Br Med J"},{"key":"10.1016\/j.dld.2008.02.003_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0168-8278(01)00094-0","article-title":"Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology","volume":"35","author":"Skelly","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2008.02.003_bib16","unstructured":"Approach to the patient with abnormal liver function tests. UpToDate 14, Feb. 2006. www.uptodate.com."},{"key":"10.1016\/j.dld.2008.02.003_bib17","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1056\/NEJM200004273421707","article-title":"Evaluation of abnormal liver enzyme results in asymptomatic patients","volume":"342","author":"Pratt","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2008.02.003_bib18","doi-asserted-by":"crossref","unstructured":"American Gastroenterological Association Medical Position Statement: Evaluation of liver chemistry tests. Gastroenterology 2005;123:1364\u20136.","DOI":"10.1053\/gast.2002.36060"},{"key":"10.1016\/j.dld.2008.02.003_bib19","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1053\/gast.2002.36061","article-title":"AGA Technical review on the evaluation of liver chemistry tests","volume":"123","author":"Green","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.02.003_bib20","doi-asserted-by":"crossref","first-page":"554","DOI":"10.7326\/0003-4819-140-7-200404060-00016","article-title":"Screening and behavioural counselling interventions in primary care to reduce alcohol misuse: recommendation statement","volume":"140","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2008.02.003_bib21","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1023\/A:1022809430756","article-title":"Prevalence of transaminase abnormalities in asymptomatic, healthy subjects participating in an executive health-screening program","volume":"48","author":"Patt","year":"2003","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2008.02.003_bib22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0025-6196(12)65219-7","article-title":"Macroenzyme as a cause of unexplained elevation of aspartate aminotransferase","volume":"62","author":"Litin","year":"1987","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.dld.2008.02.003_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0168-8278(02)00333-1","article-title":"Macroenzymes: too often overlooked","volume":"38","author":"Briani","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2008.02.003_bib24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/gut.47.3.429","article-title":"Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology","volume":"47","author":"Berasain","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.02.003_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/00365529950172880","article-title":"The clinical significance of slightly to moderately increased liver transaminases values in asymptomatic and symptomatic patients","volume":"34","author":"Mathiesen","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2008.02.003_bib26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/00365528609034632","article-title":"Liver investigation in 149 asymptomtic patients with moderately elevated activities of serum aminotransferases","volume":"21","author":"Hultcrantz","year":"1986","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2008.02.003_bib27","doi-asserted-by":"crossref","first-page":"882","DOI":"10.7326\/0003-4819-115-11-882","article-title":"Elevated serum alanine aminotransferase levels in blood donors: the contribution of hepatitis C virus","volume":"115","author":"Katkov","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2008.02.003_bib28","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1007\/BF01299887","article-title":"Serum alanine aminotransferase (ALT) elevation in asymptomatic US Air Force basic trainee blood donors","volume":"38","author":"Kundrotas","year":"1993","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2008.02.003_bib29","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1046\/j.1440-1746.2002.02846.x","article-title":"Non alcoholic fatty liver in Japan. Fatty liver in non-alcoholic nonoverweight Japanese adults: Incidence and clinical characteristics","volume":"17","author":"Omagari","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2008.02.003_bib30","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1572-0241.2003.07485.x","article-title":"Elevated AST or ALT to nonalcoholic fatty liver disease: accurate predictor of disease prevalence?","volume":"98","author":"Yu","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.02.003_bib31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0140-6736(97)11222-3","article-title":"Coeliac disease hidden by cryptogenic hypertransaminasaemia","volume":"352","author":"Volta","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2008.02.003_bib32","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/hep.510290318","article-title":"Chronic unexplained hypertransaminasaemia may be caused by occult celiac disease","volume":"29","author":"Bardella","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2008.02.003_bib33","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1590-8658(01)80014-1","article-title":"Anti tissue transglutaminase antibodies as predictors of silent coeliac disease in patients with hypertransaminasaemia of unknown origin","volume":"33","author":"Volta","year":"2001","journal-title":"Digest Liver Dis"},{"key":"10.1016\/j.dld.2008.02.003_bib34","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/gut.46.5.707","article-title":"Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase","volume":"46","author":"Bhavnani","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.02.003_bib35","first-page":"1116","article-title":"High prevalence of non-virus\/non-alcohol-related alanine-aminotransferase increase in blood donors","volume":"86","author":"Morisco","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.dld.2008.02.003_bib36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/jhep.2002.34857","article-title":"Incidence of drug-induced hepatic injuries: a French population-based study","volume":"36","author":"Sgro","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2008.02.003_bib37","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period","volume":"129","author":"Andrade","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.02.003_bib38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00228-004-0888-z","article-title":"Incidence of drug-induced liver injury in medical inpatients","volume":"61","author":"Meier","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.dld.2008.02.003_bib39","series-title":"Drug-induced Liver Disease","first-page":"227","article-title":"Clinicopathological patterns of drug-induced liver disease","author":"Maddrey","year":"2003"},{"key":"10.1016\/j.dld.2008.02.003_bib40","series-title":"Drug-induced liver disease","first-page":"725","article-title":"Occupational and environmental hepatotoxicity","author":"Tolman","year":"1993"},{"key":"10.1016\/j.dld.2008.02.003_bib41","doi-asserted-by":"crossref","unstructured":"National Institutes of Health Consensus Development Conference Statement on Celiac Disease, June 28\u201330, 2004. Gastroenterology 2005;128:S1\u2013S9.","DOI":"10.1053\/j.gastro.2005.02.007"},{"key":"10.1016\/j.dld.2008.02.003_bib42","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0168-8278(01)80874-6","article-title":"EASL International Conference on Hemochromatosis","volume":"33","author":"Adams","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2008.02.003_bib43","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1053\/jhep.2001.24783","article-title":"Diagnosis and management of hemochromatosis","volume":"33","author":"Tavill","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2008.02.003_bib44","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMra031573","article-title":"Hereditary hemochromatosis-a new look at an old disease","volume":"350","author":"Pietrangelo","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2008.02.003_bib45","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1053\/jhep.2003.50252","article-title":"AASLD Practice Guidelines. A Practice Guidlines on Wilson Disease","volume":"37","author":"Roberts","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2008.02.003_bib46","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.jhep.2004.11.013","article-title":"Wilson's disease: clinical management and therapy","volume":"42","author":"Brewer","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2008.02.003_bib47","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2008.02.003_bib48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/hep.20539","article-title":"Treatment challenges and investigational opportunities in autoimmune hepatitis","volume":"41","author":"Czaja","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2008.02.003_bib49","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0168-8278(97)80287-5","article-title":"Therapeutic effects of restricted diet and exercise in obese patients with fatty liver","volume":"27","author":"Ueno","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2008.02.003_bib50","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jhep.2005.06.008","article-title":"Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease","volume":"43","author":"Suzuki","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2008.02.003_bib51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM197507312930513","article-title":"Nomogram for Bayes's theorem","volume":"293","author":"Fagan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2008.02.003_bib52","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","article-title":"Non-alcoholic steatohepatitis: summary of an AASLD single topic conference","volume":"37","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2008.02.003_bib53","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.dld.2006.03.021","article-title":"The role of bright liver echopattern on ultrasound B mode examination in the diagnosis of liver steatosis","volume":"38","author":"Palmentieri","year":"2006","journal-title":"Dig Liv Dis"},{"key":"10.1016\/j.dld.2008.02.003_bib54","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1590-8658(02)80111-6","article-title":"Increased liver echogenicity at ultrasound examination reflects degree of steatosis but no fibrosis in asymptomatic patients with mild-moderate abnormalities of liver transaminases","volume":"34","author":"Mathiesen","year":"2002","journal-title":"Dig Liv Dis"},{"key":"10.1016\/j.dld.2008.02.003_bib55","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/gast.2002.35354","article-title":"The utility of radiological imaging in non-alcoholic fatty liver disease","volume":"123","author":"Saadeh","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.02.003_bib56","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1056\/NEJMra010852","article-title":"Celiac sprue","volume":"346","author":"Farrell","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2008.02.003_bib57","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0022-3476(05)83430-4","article-title":"Elevated serum aminotrasferase activity as a presentation of gluten-sensitive enteropathy","volume":"122","author":"Vajro","year":"1993","journal-title":"J Pediatr"},{"key":"10.1016\/j.dld.2008.02.003_bib58","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1572-0241.1999.983_f.x","article-title":"Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice","volume":"94","author":"Rostami","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.02.003_bib59","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0016-5085(98)70007-1","article-title":"Autoantibodies to tissue transglutaminase as predictors of celiac disease","volume":"115","author":"Dieterich","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.02.003_bib60","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/S0016-5085(98)70008-3","article-title":"Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease","volume":"115","author":"Sulkanen","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.02.003_bib61","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1034\/j.1399-0039.2003.00017.x","article-title":"HLA in coeliac disease: unravelling the complex genetics of a complex disorder","volume":"61","author":"Louka","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.dld.2008.02.003_bib62","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJM200011233432104","article-title":"Disease related conditions in relatives of patients with hemochromatosis","volume":"343","author":"Bulaj","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2008.02.003_bib63","doi-asserted-by":"crossref","first-page":"925","DOI":"10.7326\/0003-4819-129-11_Part_2-199812011-00002","article-title":"Diagnosis of hemochromatosis","volume":"129","author":"Powell","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2008.02.003_bib64","doi-asserted-by":"crossref","first-page":"700","DOI":"10.7326\/0003-4819-137-8-200210150-00024","article-title":"The effect of HFE Genotypes on measurements of iron overload","volume":"137","author":"Koziol","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2008.02.003_bib65","unstructured":"Kaplan MM. Diagnosis of Wilson's disease. UpToDate 13-3-2005. http:\/\/www.uptodate.com."},{"key":"10.1016\/j.dld.2008.02.003_bib66","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-199205000-00004","article-title":"Wilson's Disease","volume":"71","author":"Brewer","year":"1992","journal-title":"Medicine"},{"key":"10.1016\/j.dld.2008.02.003_bib67","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N Engl J Med"},{"issue":"Suppl.1","key":"10.1016\/j.dld.2008.02.003_bib68","first-page":"295","article-title":"Simplified diagnostic criteria for autoimmune hepatitis","volume":"42","author":"Hennes","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2008.02.003_bib69","series-title":"The Liver and its diseases","first-page":"227","article-title":"The presentation and diagnosis of 100 patients with primari biliary cirrhosis","author":"Sherlock","year":"1974"},{"key":"10.1016\/j.dld.2008.02.003_bib70","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0016-5085(80)90571-5","article-title":"Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients","volume":"78","author":"Christensen","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.02.003_bib71","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1056\/NEJM199611213352107","article-title":"Primary biliary cirrhosis","volume":"335","author":"Kaplan","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2008.02.003_bib72","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1056\/NEJM198905253202104","article-title":"Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis","volume":"320","author":"Van de Water","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2008.02.003_bib73","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.510250507","article-title":"Comparison of the clinical features and clinical course of antimitochondrial antibody positive and negative primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2008.02.003_bib74","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00001574-200405000-00013","article-title":"Sclerosing cholangitis","volume":"20","author":"MacFaul","year":"2004","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.dld.2008.02.003_bib75","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.02.003_bib76","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/bega.2001.0209","article-title":"Anti-neutrophil antibodies in primary sclerosing cholangitis","volume":"15","author":"Terjung","year":"2001","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.dld.2008.02.003_bib77","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1399-0039.2006.00738.x","article-title":"Primary Sclerosing Cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes","volume":"69","author":"Wiencke","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.dld.2008.02.003_bib78","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2249.2004.02332.x","article-title":"\u201cTrue\u201d antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?","volume":"135","author":"Muratori","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.dld.2008.02.003_bib79","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/hep.21329","article-title":"Alfa-1 antitrypsin mutations in patients with NAFLD: a high prevalence with altered iron metabolism but not with liver damage","volume":"44","author":"Valenti","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2008.02.003_bib80","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1034\/j.1399-0004.2003.00078.x","article-title":"Genetic epidemiology of alpha-1 antitrypsin in southern Europe: France, Italy, Portugal and Spain","volume":"63","author":"De Serres","year":"2003","journal-title":"Clin Genet"},{"key":"10.1016\/j.dld.2008.02.003_bib81","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/jmg.2004.023903","article-title":"Prevalence and phenotype of subjects carrying rare phenotype of subjects carrying rare variants in the Italian registry for alpha-1 antitrypsin deficiency","volume":"42","author":"Ferrarotti","year":"2005","journal-title":"J Med Genet"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086580800042X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086580800042X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T15:51:44Z","timestamp":1557503504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S159086580800042X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":81,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S159086580800042X"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2008.02.003","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}